Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
WEBJun 26, 2023 — An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
WEBNov 8, 2023 — The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months.
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
WEBNov 8, 2023 — An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
New weight loss drugs are coming, and they could burn more ... - NBC News
WEBThe next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro...
F.D.A. Approves New Obesity Drug That Will Compete With Wegovy
WEBNov 8, 2023 — The Food and Drug Administration on Wednesday approved an obesity drug from the company Eli Lilly that will be a direct competitor to the wildly popular Wegovy.
FDA Approves New Medication for Chronic Weight Management
WEBThe FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a reduced...
Eli Lilly releases data for a new weight-loss drug to tackle obesity ...
WEBApr 27, 2023 — Now, the company is seeking approval from the Food and Drug Administration for tirzepatide for chronic weight management in people who have obesity or are overweight with weight-related...
Weight Loss Drug Cuts Risk of Heart Problems, Maker Says - The …
WEBAug 8, 2023 — A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could challenge the perception of weight...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBThe FDA approved a new use for a drug to reduce the risk of serious heart problems in adults with cardiovascular disease and either obesity or overweight.
Roche to accelerate Wegovy weight loss rivals after positive trials
WEBJul 29, 2024 — Swiss pharmaceutical giant Roche said Monday it is accelerating the development of its Wegovy rival weight loss drugs following promising early stage trial data. The company’s two obesity drug ...
Skip to content